KLARSEN |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 2.27 EUR | -13.19% |
|
-23.70% | -16.54% |
| Mar. 15 | Acticor Biotech Raises EUR8 Million to Fund Emergency Stroke Treatment Development | MT |
| 2023 | Acticor Biotech’s Phase 2/3 Trial for Stroke Drug Combo on Track for 2024 Results | MT |
Chart: Technical Analysis
Technical analysis trends
| Short Term | Mid-Term | Long Term | |
|---|---|---|---|
| Trend | Neutral | Neutral | Bearish |
| Resistance | 2.990 | 3.380 | 2.990 |
| Spread/Res. | -24.08% | -32.84% | -24.08% |
| Spread/Supp. | -9.20% | +9.66% | -4.62% |
| Support | 2.500 | 2.070 | 2.380 |
- Stock Market
- Equities
- ALKLA Stock
- Charts Klarsen
